trial

The Association of Affective Resonance With Empathy Modulated by Negative Symptomatology and Oxytocin

NCTId NCT05247151
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 41 (actual)
Sponsored by Charite University, Berlin, Germany
Primary completion 2021-11-25
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
41 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2021-08-02
Primary completion
2021-11-25
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

Charite University, Berlin, GermanyLead Sponsor

Investigators

2
Marco Zierhut, Dr.Principal Investigator
Eric Hahn, PDStudy Director

Sites

1 total
Berlin, Germany

Facts & assertions

4 sourced
Enrollment
41
Phase
NA
Primary Completion Date
2021-11-25
Status
COMPLETED
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
Charite University, Berlin, Germany
company
indication
Schizophrenia Spectrum Disorders
indication
investigator
Marco Zierhut, Dr.
person
Eric Hahn, PD
person